Ventracor (ASX:VCR) Announces European Approval For New Version VentrAssist LVAD
Dec 20th 2007Drug InformationCardiovascular
Ventracor (ASX: VCR) announced CE Marking approval for the next version of the VentrAssist(tm) left ventricular assist device (LVAD) which allows it to be marketed and sold in Europe. The US Food & Drug Administration (FDA) approved use of the new version earlier this week. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
